InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001125345-24-000037 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-20 2024-02-15 MGNX Karrels James SVP, CFO, Sec F - Tax $17.40 -5,327 201.5K -3% -$92.7K
D 2024-02-20 2024-02-15 MGNX Karrels James SVP, CFO, Sec M - OptEx $0.00 +15.0K 206.8K +8% $0
D 2024-02-20 2024-02-15 MGNX Karrels James SVP, CFO, Sec M - OptEx $0.00 -15.0K 30.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-15 F D 5,327 $17.40 201,452 D — — (F2) Owned jointly with reporting person's wife.
2 Common Common Stock 2024-02-15 M A 15,003 $0.00 206,779 D — — (F1) On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
3 Derivative Restricted Stock Unit 2024-02-15 M D 15,003 $0.00 29,997 D $0.00 · — to — 15,003 Common Stock (F1) On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.